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Maine Medical Center Awarded $2.6 Million to Study Optimal
Treatment for Stroke Patients
MMC has been awarded
$2.6 million by the PatientCentered Outcomes Research Institute (PCORI) to
study whether early tracheostomy in severely ill stroke
patients who require mechanical ventilation improves survival, recovery
and the patient and family
experience.

has failed.
The research study will be
led by David Seder, M.D.,
Director of MMC’s Neurocritical Care team and a
principal investigator at the
Maine Medical Center Research Institute.

Prior studies have suggested
that when patients whose
A tracheostomy is a tempo- breathing has failed after a
rary surgical airway that
severe stroke undergo traDavid Seder, M.D., Director of MMC’s Neurocritical Care team
provides a more comforta- cheostomy early in the
ble alternative for delivering course of their recovery, the and a principal investigator at the Maine Medical Center Research
Institute, will lead the study.
oxygen to the lungs when a
stroke patient’s breathing
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Flu Masking Is In Effect
Flu is on the rise in Maine, and our Epidemiology and Infection Prevention team has confirmed cases of influenza at the
hospital. MMC is taking extra precautions to protect the
health of patients and employees. All employees should follow these guidelines:

Employees can still get a flu vaccine. Call Employee Health, 6624011, to make an appointment.



Masking is in effect. If you are not vaccinated against
influenza, you must wear a surgical mask whenever
you are within six feet of a patient. This includes times
of direct contact.



Always follow proper hand hygiene and cough etiquette.



If you are experiencing cold-like symptoms, regardless of
your influenza immunization status, you must mask.



If you have a fever, stay home.

Always follow these guidelines, and speak with your manager if you have any concerns.

Nursing Excellence Awards Nominations
Deadline: March 1
Nominations for the 2017 Nursing Excellence Awards
are now being accepted.
Guidelines and criteria are on the Nursing page of the MMC Intranet.
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risks of pneumonia and
other complications that
can lead to a prolonged
hospital stay and death are
lower.
However, the common
practice in many hospitals is
to delay the tracheostomy
procedure for up to three
weeks, in case the patient
recovers airway protective
reflexes.
“This research study tests
whether a reversible tracheostomy in patients with respiratory failure after stroke,
performed earlier than is
currently standard practice,
results in shorter duration
of coma, earlier rehab activities, shorter duration of
mechanical ventilation, improved survival and improved long-term functional outcomes,” said Dr. Seder. “If successful, the trial
could change the way such
patients are treated worldwide, and has the potential

to dramatically improve the search process. The US
outcomes of the sickest
SETPOINT2 research advistroke patients.”
sory committee will include
MMC Chaplain Alice HildeHe continued, “The study brandt, MMC stroke surviwill also assess other poten- vor family member Danielle
tial benefits of the early in- Phinney, a representative of
tervention such as a short- the American Heart Associened duration of coma, im- ation/American Stroke Asproved patient comfort and sociation and several others.
a better ability to communicate with the patient.”
“Maine Medical Center and
its Research Institute are
The study, called SETproud to be named as the
POINT2: A Pragmatic Trial U.S. coordinating center for
to Test the Effectiveness of Early the $2.6 million SETvs. Delayed Percutaneous Tra- POINT 2 clinical trial. This
cheostomy in Patients with Semulti-site, international research project is designed to
vere Stroke and Respiratory
Failure, is a collaboration
test the most effective
between MMC, the Univer- method of providing respirsity of Heidelberg and the atory support to critically ill
Neurocritical Care Society stroke patients in an intenResearch Network
sive care unit setting,” said
Donald St. Germain, M.D.,
(NCSRN).
Vice President, Research,
Dr. Seder is partnering with MMC and Director,
the Maine Medical Center MMCRI. “The results of
this project will define a
Research Institute
(MMCRI) and MMC’s Neu- critically important set of
standards to guide the care
roscience Institute on the
study. PCORI also consid- of severely ill stroke patients. It represents the deders patients, families, and
other key stakeholders to be icated efforts of highly
key collaborators in the re- skilled critical care teams

around the world and the
commitment and support
of MMC, its collaborating
institutions and PCORI to
provide the best care possible for patients suffering
from stroke.”
Dr. Seder’s award has been
approved pending completion of a business and programmatic review by
PCORI staff and issuance
of a formal award contract.
“This project was selected
for PCORI funding not only for its scientific merit and
commitment to engaging
patients and other stakeholders, but also for its potential to fill an important
gap in our health
knowledge and give people
information to help them
weigh the effectiveness of
their care options,” said
PCORI Executive Director
Joe Selby, M.D., MPH. “We
look forward to following
the study’s progress and
working with Maine Medical Center to share the results.”

